Department of Biochemistry, University of Cambridge, Cambridge, UK.
Biotechniques. 2010 Nov;49(5):822-9. doi: 10.2144/000113538.
Drug discovery requires a simple, rapid, and cost-effective method for the early identification of novel leads and elimination of poor candidates. Here we present an experimental design that fulfils these criteria, using a ligand-gated ion channel expressed in a mammalian cell line, whose function can be probed using a voltage-sensitive dye. The experimental design is novel, as it uses the same screen to identify hit fragments and to characterize them as agonists or antagonists. The results were independently validated using radioligand binding, although the new technique has several advantages over radioligand methods. A number of novel high-affinity ligands were found. The method is broadly applicable to a wide range of receptor types including ligand-gated ion channels (LGICs), voltage-gated ion channels (VGICs), and G protein-coupled receptors (GPCRs), all of which are important drug targets.
药物发现需要一种简单、快速且具有成本效益的方法,以便在早期识别新型先导化合物并淘汰不良候选物。在这里,我们提出了一种满足这些标准的实验设计,使用在哺乳动物细胞系中表达的配体门控离子通道,其功能可以使用电压敏感染料进行探测。该实验设计是新颖的,因为它使用相同的筛选方法来识别命中片段,并将其表征为激动剂或拮抗剂。尽管新技术具有优于放射性配体方法的几个优点,但结果还是通过放射性配体结合实验进行了独立验证。发现了一些新型高亲和力配体。该方法广泛适用于多种受体类型,包括配体门控离子通道(LGICs)、电压门控离子通道(VGICs)和 G 蛋白偶联受体(GPCRs),它们都是重要的药物靶标。